Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors

Rivastigmine (Riv) is a potent and selective cholinesterase (acetylcholinesterase, AChE and butyrylcholinesterase, BuChE) inhibitor developed for the treatment of Alzheimer’s disease (AD). To elucidate whether Riv causes neuronal differentiation, we examined its effect on nerve growth factor (NGF)-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada, Kazuki, Migita, Keisuke, Matsushima, Yukari, Sugimoto, Yumi, Kamei, Chiaki, Matsumoto, Taichi, Mori, Masayoshi, Matsunaga, Kazuhisa, Takata, Jiro, Karube, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296549/
https://www.ncbi.nlm.nih.gov/pubmed/30557385
http://dx.doi.org/10.1371/journal.pone.0209250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296549/
https://www.ncbi.nlm.nih.gov/pubmed/30557385
http://dx.doi.org/10.1371/journal.pone.0209250

Ejemplares similares